These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16108056)

  • 1. Proliferation and Cdk4 expression in microsatellite unstable colon cancers with TGFBR2 mutations.
    Grady WM; Willis JE; Trobridge P; Romero-Gallo J; Munoz N; Olechnowicz J; Ferguson K; Gautam S; Markowitz SD
    Int J Cancer; 2006 Feb; 118(3):600-8. PubMed ID: 16108056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.
    Biswas S; Trobridge P; Romero-Gallo J; Billheimer D; Myeroff LL; Willson JK; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2008 Feb; 47(2):95-106. PubMed ID: 17985359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.
    Grady WM; Myeroff LL; Swinler SE; Rajput A; Thiagalingam S; Lutterbaugh JD; Neumann A; Brattain MG; Chang J; Kim SJ; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
    Cancer Res; 1999 Jan; 59(2):320-4. PubMed ID: 9927040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
    Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
    Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
    Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
    Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
    Carethers JM; Pham TT
    In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
    Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
    Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.
    Biswas S; Chytil A; Washington K; Romero-Gallo J; Gorska AE; Wirth PS; Gautam S; Moses HL; Grady WM
    Cancer Res; 2004 Jul; 64(14):4687-92. PubMed ID: 15256431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
    Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
    Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers.
    Jung B; Smith EJ; Doctolero RT; Gervaz P; Alonso JC; Miyai K; Keku T; Sandler RS; Carethers JM
    Int J Cancer; 2006 May; 118(10):2509-13. PubMed ID: 16380996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers.
    Jung B; Doctolero RT; Tajima A; Nguyen AK; Keku T; Sandler RS; Carethers JM
    Gastroenterology; 2004 Mar; 126(3):654-9. PubMed ID: 14988818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
    de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
    Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.
    Grady WM; Rajput A; Myeroff L; Liu DF; Kwon K; Willis J; Markowitz S
    Cancer Res; 1998 Jul; 58(14):3101-4. PubMed ID: 9679977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability.
    Pino MS; Kikuchi H; Zeng M; Herraiz MT; Sperduti I; Berger D; Park DY; Iafrate AJ; Zukerberg LR; Chung DC
    Gastroenterology; 2010 Apr; 138(4):1406-17. PubMed ID: 20026115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability.
    Akiyama Y; Iwanaga R; Ishikawa T; Sakamoto K; Nishi N; Nihei Z; Iwama T; Saitoh K; Yuasa Y
    Cancer; 1996 Dec; 78(12):2478-84. PubMed ID: 8952554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
    Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
    Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
    Paternot S; Dumont JE; Roger PP
    Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.